Core Cap Advisors, LLC Akouos, Inc. Transaction History

Core Cap Advisors, LLC

  • $2.07 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022
BUY
$2.46 - $5.2 $221 - $468
90 New
90 $0
Q1 2022

Apr 29, 2022
SELL
$4.16 - $9.08 $374 - $817
-90 Closed
0 $0
Q4 2021

Feb 10, 2022
BUY
$7.65 - $11.38 $688 - $1,024
90 New
90 $1,000

About Akouos, Inc.

AKUS Quotes by TradingView
  • Ticker AKUS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,929,000
  • Description
  • Akouos, Inc., a precision genetic medicine company, developing gene therapies to restore, improve, and preserve physiologic hearing for individuals. The company's precision genetic medicine platform incorporates a proprietary adeno-associated viral vector library and a novel delivery approach. Its lead product candidate is AK-OTOF, a gene therap...
More about AKUS
Track This Portfolio

Track Core Cap Advisors, LLC Portfolio

Follow Core Cap Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Core Cap Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Core Cap Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email